search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Drug delivery


AI-driven delivery I


Artificial intelligence (AI) has emerged as a transformative force in healthcare, with applications spanning diagnostics to drug development. Now, AI/ML models are revolutionising the design of delivery systems, from improving permeability to creating more effective drug carriers. Monica Karpinski delves into the rapidly evolving field of AI-driven drug delivery systems to explore the implications of these advances.


t’s notoriously difficult to gauge how well a drug can reach the brain. For ethical reasons, human trials aren’t typically possible. That leaves scientists with computational simulations, lab experiments or animal studies. Yet none of these options are perfect. For instance, simulations can be limited in what they are able to model and must be validated by experimental data. And while animal studies may be our most faithful recreation of in-human delivery, our current means of measuring permeability aren’t especially precise. Here, to ascertain how much of the drug has crossed the blood-brain barrier, scientists give the drug to a rat,


16


then take out its brain and weigh it, explains senior lecturer at the School of Medicine, Pharmacy and Biomedical Sciences at Portsmouth University, Christian Jorgensen. “And then they’re making some very difficult mathematical estimation of how much must have got [into the brain]. But that’s it.” To paint a clearer picture, Jorgensen and his colleagues are working with AI models that can be trained to predict whether a drug will successfully reach the brain. It’s still a work in progress – Jorgensen notes that the field is still very underdeveloped – but this approach might help us gain novel insight into the odds


World Pharmaceutical Frontiers / www.worldpharmaceuticals.net


innni/www.shutterstock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58